Phase III BMT CTN 0901 Trial of Allogeneic Stem Cell Transplant After High- versus Reduced-Intensity Conditioning for Patients with MDS or AML


Phase III BMT CTN 0901 Trial of Allogeneic Stem Cell Transplant After High- versus Reduced-Intensity Conditioning for Patients with MDS or AML
Slides from a presentation at ASH 2015 

Scott BL et al. Results of a Phase III randomized, multi-center study of allogeneic stem cell transplantation after high versus reduced intensity conditioning in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901. Proc ASH 2015;Abstract LBA-8.